Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
Endocannabinoids and neurodegenerative diseases.
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
Progenitor-derived Oligodendrocyte Culture System from Human Fetal Brain.
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis (PROMESS)
[Vitamin D for prevention of diseases?].
CCSVI and MS: no meaning, no fact.
Catheter venography and endovascular treatment of chronic cerebrospinal venous insufficiency.
High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis.
Segway use in individuals with multiple sclerosis.
Individual variation of human sphingosine 1-phosphate receptor 1 coding sequence leads to heterogeneity in receptor function and drug interactions.
Graves' disease after treatment with Alemtuzumab for multiple sclerosis.
Kappa free light chains: diagnostic and prognostic relevance in MS and CIS.
Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient.
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Comorbid Multiple Sclerosis and TDP-43 Proteinopathy in a Gulf War Sea Captain.
Conference Report: Multiple Sclerosis Update: Hot topics from 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases.
Intraventricularly injected Olig2-NSCs attenuate established relapsing-remitting EAE in mice.
Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies.
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis.
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors.
Moving towards the pan-European unification of Multiple Sclerosis Nurses: a consensus paper.
The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.
Pages
« first
‹ previous
…
169
170
171
172
173
174
175
176
177
…
next ›
last »